Haymaker III (HYAC) to Combine with Biote in $737M Deal
Haymaker Acquisition Corp. III (NASDAQ:HYAC) has entered into a definitive agreement to combine with hormone-optimization medical practice builder Biote at an enterprise value of $667 million, or 4.0-4.2x multiple to 2022E sales. Irving, Texas-based Biote is a high-growth, differentiated medical practice-building business with a bioidentical hormone replacement optimization platform and complementary nutraceutical business. The companyRead More